AstraZeneca PLC
www.astrazeneca.com
Latest From AstraZeneca PLC
Deal Watch: Themis Leverages Measles Vector Platform In Collaboration With Merck & Co.
In its first big pharma deal, Austrian biotech will develop experimental vaccines for Merck against an undisclosed target. Innovent licenses Chinese rights to Lilly diabetes candidate, while Novartis gets option to Iconic’s preclinical ophthalmology program.
Keeping Track: US FDA Greenlights Two More Novel Drugs, But Smacks Down Golodirsen
DREAMM-2 Put GSK’s BCMA Drug In Pole Position In Multiple Myeloma
The DREAMM-2 trial of the antibody-drug conjugate belantamab mafodotin in relapsed/refractory multiple myeloma patients has hit its primary endpoint, giving GSK a chance to file for approval before its BCMA rivals.
AstraZeneca Buys Priority Review Voucher With Two Big Filings On The Horizon
AstraZeneca paid $95m to Swedish Orphan Biovitrum for the voucher, which it could use to expedite the FDA review of roxadustat or trastuzumab deruxtecan.
Company Information
- Industry
- Pharmaceuticals
- Therapeutic Areas
- Cancer
- Cardiovascular
- Gastrointestinal
- Infectious & Viral Diseases
- Inflammation
- Neurology, Nervous System
- Respiratory, Pulmonary
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
Europe
-
Western Europe
-
UK
-
UK
-
Western Europe
-
Europe
- Company Type
- Big Pharma
- Parent & Subsidiaries
-
AstraZeneca PLC
- Acerta Pharma BV
- Ardea Biosciences Inc.
- Arrow Therapeutics Ltd.
- Astra Arcus
- Astra Draco AB
- Astra GMBH
- Astra Hassle AB
- Astra Japan Ltd.
- AstraZeneca AB
- AstraZeneca KK
- AstraZeneca LP
- AstraZeneca Pharma India Ltd.
- AstraZeneca Pharmaceuticals LP
- AstraZeneca UK Ltd.
- Australian Monoclonal Antibody Development Pty Ltd
- Cambridge Research Biochemicals Inc.
- Cambridge Research Biochemicals Ltd.
- ICI Americas Inc.
- ICI Australia
- KuDOS Pharmaceuticals Ltd.
- Laboratorio Ifesa SA
- MedImmune Inc.
- MedImmune LLC
- Novexel SA
- Omthera Pharmaceuticals Inc.
- Pearl Therapeutics Inc.
- Salick Health Care Inc.
- Simes SRL
- Stuart Disease Management Services
- Stuart Pharmaceuticals Inc.
- Symbicom AB
- Zeneca Agrochemicals
- Zeneca Group PLC
- Zeneca Inc.
- Zeneca Pharma Inc.
- Zeneca Pharmaceuticals
- ZS Pharma Inc.
- Senior Management
-
Pascal Soriot, CEO
Marc Dunoyer, CFO
Sean Bohen, MD, PhD, EVP, Global Medicines Dev. & CMO - Contact Info
-
AstraZeneca PLC
Phone: (44) 20 7604 8000
2 Kingdom St.
London, W2 6BD
UK
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice